Glo1 inhibitors are actively being tested for cancer therapy, as many cancer types present elevated rates of glycolysis [7], a condition known to augment MGO formation and toxicity, where Glo1 activity improves cancer cell survival [6,8]. The gene discussed is GLO1; the disease is cancer.